Poorly differentiated chordoma with SMARCB1/INI1 loss: a distinct molecular entity with dismal prognosis

Acta Neuropathol. 2016 Jul;132(1):149-51. doi: 10.1007/s00401-016-1574-9. Epub 2016 Apr 11.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Biomarkers, Tumor / genetics
  • Biomarkers, Tumor / metabolism
  • Brain Neoplasms / diagnosis
  • Brain Neoplasms / genetics
  • Brain Neoplasms / metabolism
  • Brain Neoplasms / pathology
  • Child
  • Child, Preschool
  • Chordoma / diagnosis*
  • Chordoma / genetics
  • Chordoma / metabolism*
  • Chordoma / pathology
  • Cluster Analysis
  • DNA Copy Number Variations
  • DNA Methylation*
  • Diagnosis, Differential
  • Female
  • Humans
  • Infant
  • Male
  • Prognosis
  • Rhabdoid Tumor / diagnosis
  • Rhabdoid Tumor / genetics
  • Rhabdoid Tumor / metabolism
  • Rhabdoid Tumor / pathology
  • SMARCB1 Protein / deficiency*
  • SMARCB1 Protein / genetics
  • Survival Analysis
  • Teratoma / diagnosis
  • Teratoma / genetics
  • Teratoma / metabolism
  • Teratoma / pathology

Substances

  • Biomarkers, Tumor
  • SMARCB1 Protein
  • SMARCB1 protein, human

Supplementary concepts

  • Teratoid Tumor, Atypical